Corvus Pharmaceuticals, Inc. - Special Call Transcript
Greetings, and welcome to the Corvus Pharmaceuticals Update Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Zack Kubow of Pure Communications. Thank you. You may begin.
Thank you, operator, and good morning, everyone. Thank you for joining us for the Corvus Pharmaceuticals conference call to discuss the initiation of a COVID-19 clinical trial. This call is also being webcast with presentation slides. We encourage participants to join the webcast in order to view the slides. You can find the link to join the webcast on the Investor Relations home page of the Corvus website.
Joining me on the call from the company are Dr. Richard Miller, Chief Executive Officer; Leiv Lea, Chief Financial Officer; Dr. Mehrdad Mobasher, Chief Medical Officer; and Dr. Stephen Willingham, Director of Translational Biology, who leads our COVID-19 research program. The executive team will open the call with some prepared remarks followed by a question-and-answer period.
Turning to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
